4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-282740
Chief Medical Officer sold 41,845 shares at an average $21.08 ($882,203)
- Chief Medical Officer acquired 36,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Janku Filip · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-23 | Exercise or conversion : show line 1 in the form 10b5-1 | +6,000 | $7.56 | $45,360 | 71,837 | D |
| 2026-06-23 | Sale : show line 2 in the form 10b5-1 | −11,845 | $20.22 | $239,522 | 59,992 | D |
| 2026-06-24 | Exercise or conversion : show line 3 in the form 10b5-1 | +30,000 | $7.56 | $226,800 | 89,992 | D |
| 2026-06-24 | Sale : show line 4 in the form 10b5-1 | −30,000 | $21.42 | $642,681 | 59,992 | D |
| Open-market sales · 41,845 sh · avg $21.08 · $882,203 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-23 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −6,000 | 96,000 | D |
| 2026-06-24 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −30,000 | 66,000 | D |
Loading xslF345X06/ownership.xml…